Hospital News and Research

RSS

Researchers begin placebo-controlled trial to test drug treatment for Rett syndrome

Researchers at Children's Hospital Boston have begun a randomized, placebo-controlled trial to test a potential drug treatment for Rett syndrome, the leading known genetic cause of autism in girls.

16 Dec 2010

Genetic breakthrough in lung cancer

For the study the team studied samples of lung tumors and nearby healthy lung tissue from 30 patients and examined the samples for the presence of messenger ribonucleic acid (mRNA) associated with 48 known genes for molecules called nuclear hormone receptors. Then they compared the active genes with patient outcomes and found that the expression of genes for certain nuclear hormone receptors helped predict patient survival.

16 Dec 2010

Liver cancer in cirrhotic patients effectively treated with radiofrequency ablation

Researchers from Italy determined that radiofrequency ablation (RFA) is a safe and effective therapy for managing hepatocellular carcinoma (HCC) in cirrhotic patients. The high repeatability of RFA is advantageous in controlling recurrences of cancerous tumors in the liver. Results of this 10-year retrospective study are available in the January 2011 issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD).

16 Dec 2010

Stem cell therapy gives sight to four year old

Izabelle Evans, only four years of age, was born blind but in a medical miracle has been given sight. After a stem cell treatment in China she can see. Her parents James Evans and Hollie McHugh are “over the moon” that their daughter can finally see them. As of now she can see only 3ft away. The treatment that cost the family £50,000.

16 Dec 2010

Akonni receives $150,000 Phase I NSF grant to assess feasibility of developing lab-on-a-film microarray device

Akonni Biosystems, a molecular diagnostics company that develops, manufactures, and plans to market sophisticated molecular testing devices for diagnosing infectious diseases and human genetic disorders, announced today the receipt of a $150,000 Phase I Grant from the National Science Foundation (NSF). This initial round of funding from NSF will enable Akonni to assess the feasibility of developing a lab-on-a-film microarray device that can be manufactured in a reel-to-reel format.

16 Dec 2010

Genome is one more factor to blame for unwanted pounds

In addition to fast food, desk jobs, and inertia, there is one more thing to blame for unwanted pounds-our genome, which has apparently not caught up with the fact that we no longer live in the Stone Age.

16 Dec 2010

RFA highly valuable therapy for controlling cancerous nodules

16 Dec 2010

Guardian 24/7 selects Glowpoint's video managed services for remote diagnosis and patient collaboration

Glowpoint, Inc., a provider of cloud-based managed services for telepresence, video conferencing and collaboration, today announced that Guardian 24/7, a health care provider for high-profile executives, has selected Glowpoint's video managed services for providing remote diagnosis and patient collaboration using high-quality video conferencing.

16 Dec 2010

RAD to restore SCI's Radiation Treatment Center

Swedish Cancer Institute (SCI) has embarked on a bold approach to rapidly restore community-based radiotherapy cancer treatment in the Ballard community utilizing state-of-the-art building technology that is swift and green.

16 Dec 2010

MedicAlert Foundation's 'Code of Conduct' helps evaluate integrity of emergency medical information

The non-profit MedicAlert Foundation published a "Code of Conduct" in an effort to help consumers evaluate the integrity of organizations providing emergency medical information and identification services. In addition, as part of the "Code of Conduct" the Foundation has established business practice standards for medical information and identification service organizations that house consumer health information. Across the country millions of consumers are using personal health records, emergency medical information services, personal medical alarms systems or medical identification jewelry services.

16 Dec 2010

Living near freeway linked to increased risk of autism

Living near a freeway may be associated with increased risk of autism, according to a study published by a team of researchers from Children's Hospital Los Angeles, the Keck School of Medicine of the University of Southern California (USC) and the UC Davis MIND Institute.

16 Dec 2010

Oxygen Biotherapeutics and SMP sign Binding Letter of Intent for joint chronic ischemic wound research

Oxygen Biotherapeutics, Inc. and privately held Sarasota Medical Products, Inc. (SMP) of Sarasota, FL, today announced they signed a Binding Letter of Intent to determine the feasibility of pursuing a joint research and development venture for treating chronic ischemic wounds. The venture will be based on combining Oxygen's Wundecyte™ PFC formulation with SMP's topical medical devices.

16 Dec 2010

UT Southwestern and Rabin Medical Center enter innovative 5-year affiliation agreement

UT Southwestern Medical Center and Rabin Medical Center, Israel, two of the world's top academic medical centers, announced today that they have entered into an innovative affiliation agreement for the next five years.

16 Dec 2010

BioAlliance wins grant and award for new applications of mucoadhesive Lauriad technology

BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, announces the award of a grant from the ANR (the French state Research National Agency) and a label award from both "Clusters of excellence", Medicen Paris Region and Atlanpole, for two new applications of its mucoadhesive Lauriad™ technology. These projects are dedicated to the development of new biological products based on the Lauriad™ technology allowing mucous penetration of a biologically active compound.

16 Dec 2010

Combination therapy improves survival rates in patients with advanced non-small cell lung cancer

A combination therapy for treating cancer discovered at the University of Colorado Cancer Center showed improved survival rates in patients with advanced non-small cell lung cancer (NSCLC), according to results from a double-blind, placebo-controlled phase 2 trial run by Syndax Pharmaceuticals.

16 Dec 2010

SBUMC to unveil one-of-a-kind neuroendovascular simulator

Stony Brook University Medical Center will unveil this Friday a one-of-a-kind neuroendovascular simulator that recreates vasculature in the brain, including scenarios of damaged vessels from acute stroke, brain aneurysms, and other cerebrovascular anomalies. Affectionately known in the lab as "Headley".

16 Dec 2010

State roundup: Minn. to add more adults to Medicaid; Mass. Gov. seeks savings in pensions and health care costs; Ariz. bishop and hospital spar over control

Minnesota can add 95,000 low-income adults to its Medicaid rolls, vastly improving their medical care, at no additional cost to the state, two officials at the state Department of Human Services told legislators Tuesday (Wolfe, 12/15).

16 Dec 2010

Use of vitamin K antagonists is driven by availability of oral formulation

Arlington Medical Resources (AMR), a provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries, finds that, in the treatment of atrial fibrillation, surveyed European cardiologists indicate that use of vitamin K antagonists, as a class, is primarily driven by the availability of an oral formulation, overall low cost and widespread inclusion on European medical society guidelines and hospital formularies.

16 Dec 2010

Study finds occurrence of infection following surgical procedures

Delaying elective surgical procedures after a patient has been admitted to the hospital significantly increases the risk of infectious complications and raises hospital costs, according to the results of a new study in the December issue of the Journal of the American College of Surgeons.

16 Dec 2010

New findings says TRIM24 protein plays active role in breast cancer formation

The recently identified TRIM24 protein plays an active role in pushing normal breast cells into rapid cell proliferation and, potentially, into breast cancer.

16 Dec 2010

Hospital News and Research

Researchers begin placebo-controlled trial to test drug treatment for Rett syndrome

Genetic breakthrough in lung cancer

Liver cancer in cirrhotic patients effectively treated with radiofrequency ablation

Stem cell therapy gives sight to four year old

Akonni receives $150,000 Phase I NSF grant to assess feasibility of developing lab-on-a-film microarray device

Genome is one more factor to blame for unwanted pounds

RFA highly valuable therapy for controlling cancerous nodules

Guardian 24/7 selects Glowpoint's video managed services for remote diagnosis and patient collaboration

RAD to restore SCI's Radiation Treatment Center

MedicAlert Foundation's 'Code of Conduct' helps evaluate integrity of emergency medical information

Living near freeway linked to increased risk of autism

Oxygen Biotherapeutics and SMP sign Binding Letter of Intent for joint chronic ischemic wound research

UT Southwestern and Rabin Medical Center enter innovative 5-year affiliation agreement

BioAlliance wins grant and award for new applications of mucoadhesive Lauriad technology

Combination therapy improves survival rates in patients with advanced non-small cell lung cancer

SBUMC to unveil one-of-a-kind neuroendovascular simulator

State roundup: Minn. to add more adults to Medicaid; Mass. Gov. seeks savings in pensions and health care costs; Ariz. bishop and hospital spar over control

Use of vitamin K antagonists is driven by availability of oral formulation

Study finds occurrence of infection following surgical procedures

New findings says TRIM24 protein plays active role in breast cancer formation

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News